We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

74 hedge funds and large institutions have $149M invested in abrdn Life Sciences Investors in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $136M → $149M (+$12.5M)

0.98% more ownership

Funds ownership: 35.17% → 36.15% (+0.98%)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

1% less funds holding

Funds holding: 75 → 74 (-1)

29% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 28

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
74
Holders Change
-1
Holders Change %
-1.33%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
20
Reduced
28
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PCM
Penserra Capital Management
California
+$11.7M
2
SIA
Sit Investment Associates
Minnesota
+$3.4M
3
KIM
Karpus Investment Management
New York
+$972K
4
WAM
WNY Asset Management
New York
+$320K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$228K

Top Sellers

1
RL
RPO LLC
Connecticut
-$3.67M
2
BFM
Boothbay Fund Management
New York
-$1.65M
3
AW
Atlas Wealth
Ohio
-$1.19M
4
AA
AQR Arbitrage
Connecticut
-$1.12M
5
1CP
1607 Capital Partners
Virginia
-$1.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$51.7M – – –
PCM
2
Penserra Capital Management
California
$11.7M +$11.7M +776,002 New
AIA
3
Absolute Investment Advisers
Florida
$8.16M -$330K -21,816 -4%
Morgan Stanley
4
Morgan Stanley
New York
$7.38M -$6.86K -453 -0.1%
KIM
5
Karpus Investment Management
New York
$7.07M +$972K +64,214 +16%
SIA
6
Sit Investment Associates
Minnesota
$6.29M +$3.4M +224,420 +116%
NIM
7
Needham Investment Management
New York
$5.32M +$165K +10,904 +3%
1CP
8
1607 Capital Partners
Virginia
$5.27M -$1.06M -69,778 -17%
FHA
9
Flagship Harbor Advisors
Massachusetts
$4.72M +$160K +10,603 +4%
Allspring Global Investments
10
Allspring Global Investments
North Carolina
$4.23M -$1M -66,319 -19%
AA
11
AQR Arbitrage
Connecticut
$3.97M -$1.12M -73,922 -22%
Bank of America
12
Bank of America
North Carolina
$2.94M -$340K -22,498 -10%
QL
13
Quarry LP
New York
$2.8M -$306K -20,190 -10%
Cetera Investment Advisers
14
Cetera Investment Advisers
Illinois
$2.59M +$228K +15,044 +10%
RJFSA
15
Raymond James Financial Services Advisors
Florida
$2.55M +$109K +7,189 +4%
LPL Financial
16
LPL Financial
California
$2.38M +$30.5K +2,016 +1%
AAM
17
Advisors Asset Management
Colorado
$2.31M -$40K -2,646 -2%
Ameriprise
18
Ameriprise
Minnesota
$2.15M -$171K -11,323 -7%
1WA
19
180 Wealth Advisors
Washington
$2.02M -$31.3K -2,065 -2%
Janney Montgomery Scott
20
Janney Montgomery Scott
Pennsylvania
$1.28M -$85.8K -5,669 -6%
UPS
21
UHLMANN PRICE SECURITIES
Illinois
$1M +$1.01M +66,519 New
BBPWM
22
Blue Bell Private Wealth Management
Pennsylvania
$946K +$7.16K +473 +0.8%
UBS Group
23
UBS Group
Switzerland
$758K -$102K -6,770 -12%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$756K +$79.2K +5,231 +12%
RJA
25
Raymond James & Associates
Florida
$666K +$72.8K +4,812 +12%
1
2 3 4

HQL Hedge Fund Activity: Q3 2024 in Review

74 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2024, worth a combined $149M — up 9.2% from $136M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of HQL and 10 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 20 added.

The largest buyer was Penserra Capital Management, opening a new position worth an estimated $11.7M. The largest seller was RPO LLC, exiting entirely with an estimated $3.67M sold.

  • 74 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2024, down from 75 in Q2 2024.
  • Funds reported $149M of abrdn Life Sciences Investors stock for Q3 2024, up 9.2% quarter-over-quarter.
  • 10 funds opened new abrdn Life Sciences Investors positions in Q3 2024 and 11 closed out, a net change of -1 holder.
  • The largest abrdn Life Sciences Investors buyer in Q3 2024 was Penserra Capital Management, an estimated $11.7M added.
  • The largest abrdn Life Sciences Investors seller in Q3 2024 was RPO LLC, an estimated $3.67M sold.

Based on aggregated 13F filings for Q3 2024.